Pharmacists in Forest, Mississippi


13 Pharmacists found in Forest
female pharmacist

Johana Lizeth Mcdonald, PHARMD


Pharmacist
219 N Woodland Dr, Forest, MS 39074
601-469-3393     601-469-5965

male pharmacist

Mr. John Richard Hunt, RPH


Pharmacist
675 Mccormick Rd, Forest, MS 39074
601-469-2974     601-469-5933

male pharmacist

Dr. Joseph Andrew Sistrunk, PHARMD


Pharmacist
822 Highway 35 N, Forest, MS 39074
601-469-1540     601-469-2904



female pharmacist

Dr. Keely Russell, PHARMD


Pharmacist
822 Highway 35 N, Forest, MS 39074
601-469-1540    

female pharmacist

Lauren Oswalt


Pharmacist
1309 Highway 35 S, Forest, MS 39074
601-469-2190    

female pharmacist

Mrs. Lindsay Leann Harrison, PHD


Pharmacist
1309 Ms-35, Forest, MS 39074
601-469-2190    

female pharmacist

Dr. Margaret Lee Jones, PHARM.D.


Pharmacist
1309 Highway 35 S, Forest, MS 39074
601-469-2190     601-469-2176

female pharmacist

Megan Marie Avent, PHARMD


Pharmacist
1309 Highway 35 S, Forest, MS 39074
601-469-2190    

female pharmacist

Dr. My Quang Thi Pham, PHARM.D.


Pharmacist
219 N Woodland Dr, Forest, MS 39074
601-469-3393    

female pharmacist

Natalie Grundel


Pharmacist
1309 Highway 35 S, Forest, MS 39074
601-469-2190    

female pharmacist

Stephanie Carroll Hodges, PHARMD


Pharmacist
1309 Highway 35 S, Forest, MS 39074
601-469-2190    

male pharmacist

Dr. Trenton D Lott, PHARM.D.


Pharmacist
237 Woodland Dr, Forest, MS 39074
601-469-2242     601-469-4547

male pharmacist

Dr. Tyler Mcintosh, PHARMD


Pharmacist
219 N Woodland Dr, Forest, MS 39074
601-469-3393    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.